About Us
Key Dates in Our History
- 2007
- Volume Interactions Pte Ltd. becomes BRACCO AMT, Inc.
- 2006
- Launch of the Dextroscope™ at the American Association of Neurological Surgeons (AANS) Annual Meeting 2006
- Volume Interactions received ISO 13485 Certification for establishing and applying a quality management system for medical devices:
- Design, manufacturing, and marketing of virtual reality medical devices
- Diagnostics imaging processing and surgical planning
- Opened Operations Hub in USA (Minneapolis, MN)
- 2004
- Attained China SFDA Registration for Dextroscope™ and Dextrobeam™
- Obtained Health Science Authority (Singapore) clearance for image processing and surgical planning systems
- Received Europe CE Mark for Dextroscope™ and Dextrobeam™
- Dextroscope™ was used in the separation of the German conjoined twins, Lea and Tabea Block, by Dr. Ben Carson
- 2003
- Received CE Declaration on Conformity
- Opened manufacturing and integration facilities in Italy and Singapore
- Received marketing clearance by Health Science Authority (Singapore)
- Became Member of the Italian Chamber of Commerce
- Successful Re-Accreditation to ISO 9001 : 2000
- 2002
- Dextroscope™ and Dextrobeam™ received FDA 510(k) and CE Certification
- Volume Interactions was acquired by the Bracco Group
- 2001
- Dextroscope™ was used in the separation of the Nepali conjoined twins (Jamuna & Ganga) by Dr. Keith Goh in Singapore General Hospital
- Volume Interactions received the ISO 9000 Certification
- 2000
- Establishment of Volume Interactions Pte Ltd.
- 1998
- Dextroscope™ was used in the separation of the Zambian conjoined twins by Dr. Ben Carson
